BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 14, 2006
View Archived Issues
Radius acquires rights to ER-beta selective compounds
Read More
Reimbursement progress for cintredekin besudotox
Read More
Series A financing at Cabrellis to fund development of Calsed
Read More
Second analytical method validated for PT-401
Read More
Neose Technologies receives research milestone payment from Novo Nordisk
Read More
QR-443 prevents cachexia in mice
Read More
rHuPH20 studied for absorption enhancement of large molecule protein therapeutic
Read More
Shire makes strides in second quarter
Read More
Phase I findings for AZD-103
Read More
Phase II trial of FM-VP4 on schedule
Read More
Combining immunotherapies with antitumor agents for the treatment of metastatic renal cell carcinoma
Read More
Second phase III trial of Sativex in central neuropathic pain due to MS
Read More
Biota receives award for development of Flunet compounds
Read More
Findings of investigation into patient death in phase II DAC:GRF trial
Read More
Withdrawal of E.U. marketing authorization for Fortovase
Read More
WX-671 begins study in cancer patients
Read More
Epigenomics enters into R&D agreement with J&J
Read More
Immunicon enters into agreements with AstraZeneca
Read More
Homer-1a: a novel target for pain therapeutics
Read More
Novel therapeutic agents for respiratory disorders disclosed in recent patents
Read More
New therapeutic agents for metabolic disorders reported in recent patent literature
Read More
Novel P2Y1 receptor antagonists for thrombotic disorders emerge from Bristol-Myers Squibb R&D
Read More
Activation of EGFR in optic nerve astrocytes mediates optic nerve damage in rats
Read More
Augmentation strategy with memantine for resistant depression to be evaluated in clinical study
Read More
Ophthalmic ciclosporin to be tested for the treatment of ocular rosacea in new clinical trial
Read More